环氧合酶与前列腺素在胃肠道肿瘤免疫及微环境中的作用
本文综述环氧合酶-2-前列腺素E2通路对胃肠道肿瘤发生发展的影响,重点汇总该通路诱导肿瘤免疫逃逸的新近进展。非甾体抗炎药可抑制胃肠道肿瘤发生、生长和转移,提示环氧合酶及其下游脂质产物是炎症与癌症的链接之一。临床前研究显示该通路促进胃肠道肿瘤发展,而克服肿瘤免疫逃逸是免疫治疗的主要挑战。
要点
- 非甾体抗炎药可抑制胃肠道肿瘤发生、生长和转移
- 环氧合酶-2-前列腺素E2通路促进胃肠道肿瘤发展
- 该通路诱导肿瘤免疫逃逸,是免疫治疗需克服的环节
核心结论
- 环氧合酶-2-前列腺素E2通路可能链接炎症与胃肠道癌症,并通过诱导肿瘤免疫逃逸促进肿瘤发展。
研究设计与样本
- 综述,总结环氧合酶-2-前列腺素E2通路对胃肠道肿瘤发展的影响及近期免疫逃逸研究进展。
主要发现
- 非甾体抗炎药抑制胃肠道肿瘤发生、生长和转移的证据支持环氧合酶及其下游脂质产物参与炎症致癌。
- 临床前研究证实环氧合酶-2-前列腺素E2通路促进胃肠道肿瘤发展。
- 近二十年广泛研究后,近期研究描述了该通路对宿主防御转化上皮细胞的影响。
临床怎么用
- 关注环氧合酶-2-前列腺素E2通路作为胃肠道肿瘤免疫逃逸干预的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic inflammation is a known risk factor for gastrointestinal cancer. The evidence that nonsteroidal anti-inflammatory drugs suppress the incidence, growth, and metastasis of gastrointestinal cancer supports the concept that a nonsteroidal anti-inflammatory drug target, cyclooxygenase, and its downstream bioactive lipid products may provide one of the links between inflammation and cancer. Preclinical studies have demonstrated that the cyclooxygenase-2-prostaglandin E2 pathway can promote gastrointestinal cancer development. Although the role of this pathway in cancer has been investigated extensively for 2 decades, only recent studies have described its effects on host defenses against transformed epithelial cells. Overcoming tumor-immune evasion remains one of the major challenges in cancer immunotherapy. This review summarizes the impacts of the cyclooxygenase-2-prostaglandin E2 pathway on gastrointestinal cancer development. Our focus was to highlight recent advances in our understanding of how this pathway induces tumor immune evasion.
引用
- Wang D, Cabalag CS, Clemons NJ, et al. Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer. Gastroenterology. 2021. PMID: 34606846. doi:10.1053/j.gastro.2021.09.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。